Gemtuzumab Oz Ozogamicin represents a important development in the management of acute myeloid leukemia, particularly severe myeloblastic leukemia (AML). This agent combines a humanized immunoglobulin aimed for the receptor cell surface protein located on abnormal populations with a cytotoxic pay